Advisory Board
“Our kernel of an idea to train a lens on the forgotten yet heroic women of science has resonated. Enthusiasm for this project from a wide array of STEM experts has been remarkable. We’re especially pleased to announce that Maria Klawe, President of Harvey Mudd College, was one of the first to endorse the project and has signed on as chair of our Advisory Board.”— Katie Hafner
“Lost Women of Science is paying it both ways – forward as well as back. Revisiting vital history, Lost Women of Science will also inspire young women working their way through the STEM pipeline, which is a core part of our mission. I am proud of the team and to serve with the other phenomenal women on the Lost Women of Science Advisory Board.”— Maria Klawe
Maria Klawe, Ph.D.
Dr. Klawe, a renowned mathematician and computer scientist, left Princeton in 2006, where she was Dean of engineering and applied science, to begin her tenure as Harvey Mudd College’s fifth president in 2006. She is the first woman to lead the College since its founding in 1955.
Jane Grogan, Ph.D.
Dr. Jane Grogan is a renowned scientist in the fields of immunology, oncology and cell therapy with over two decades of biotech and life sciences industry experience. Dr. Grogan is currently Executive Vice President and Head of Research, at Biogen. Prior to this she served as the Chief Scientific Officer at Graphite Bio and ArsenalBio, both cell and gene therapy companies, and as Head of Adaptive Tumor Immunity within Research at Genentech. She also created and hosted the popular podcast, Two Scientists Walk Into a Bar.
Sian L. Beilock, Ph.D.
Dr. Sian Leah Beilock is the 19th president of Dartmouth College. A cognitive scientist by training, Beilock is one of the world’s leading experts on performance under pressure. She has authored two critically-acclaimed books — Choke and How the Body Knows Its Mind — and 120 peer-reviewed papers. Her 2017 TED talk has been viewed over 2.7 million times.
Prior to Dartmouth, Beilock served for six years as President of Barnard College at Columbia University, and twelve years at the University of Chicago, where she was the Stella M. Rowley Professor of Psychology and Executive Vice Provost.
.jpg)
Linda Grais, M.D., J.D.
Dr. Grais is a successful biotech executive, board member of several life sciences companies, and a Lecturer at Stanford Graduate School of Business. She has extensive experience in the healthcare field as a physician and entrepreneur. Her medical degree is from Yale University, and her law degree is from Stanford University.
Ann Sacher, M.D.
Dr. Sacher, a retired general surgeon, currently serves on the Board of Trustees of Barnard College, is a member of the advisory board at the Johns Hopkins Center for Humanitarian Health, and as vice-chair of the board of Columbia’s Global Mental Health Program.
Ellen B. Lyon, Ph.D.
Dr. Lyon holds a PhD in Science Education from University of Texas at Austin where she has “taught it all,” including AP Physics, Engineering, and Geology at the high school level, as well as Science and Humanity at UT San Antonio.
Paula Goodwin, J.D.
Ms. Goodwin is a partner at Perkins Coie LLP, an international law firm. Ms. Goodwin is counsel to the Lost Women of Science Initiative on legal matters. Her interest in the topic of women in S.T.E.M. fields stems in part from observing her husband’s field — paleontology — and hearing stories of women overcoming gender bias to shine.
Daphne Higgs, J.D.
Daphne Higgs is a partner in the Palo Alto office of Morrison Foerster and a member of the firm’s Technology Transactions Group. Daphne advises clients on complex technology transactions with an emphasis on artificial intelligence, machine learning, open source, consumer products, eXtended reality, entertainment, cloud offerings, drones, and transfers of technologies from universities.
Joan Y. Reede, MD, MPH, MS, MBA
As Dean for Diversity and Community Partnership and Professor of Medicine at Harvard Medical School, as well as Professor of Society, Human Development and Health at Harvard's T.H. Chan School of Public Health, Dr. Reede has a passion for mentoring diverse individuals in the biosciences. Her duties include development and management of a comprehensive program that provides leadership, guidance, and support to promote the increased recruitment, retention, and advancement of diverse students, trainees, and faculty. She is a member of the National Academy of Medicine and a fellow of the American Association for the Advancement of Science.
Sarah Greene
Sarah Greene is CEO of RapidScience.org and consultant to Aligning Science Across Parkinson's. She served as Executive Director of Cancer Commons, co-founded the Journal of Participatory Medicine (and its society), was Editor-in-Chief of The Scientist, and was Senior Program Director of The New York Times Health vertical and served at the New York Academy of Sciences.
Pamela Templer, Ph.D
Pamela Templer, PhD, is chair and professor in the Department of Biology and director of the PhD Program in Biogeoscience at Boston University. She is a biogeochemist who has published widely on the effects of air pollution, climate change, and urbanization on forest ecosystems, water, and air quality.
Andy Cunningham
The founder and president of Cunningham Collective, a marketing, brand and communication strategy firm dedicated to bringing innovation to market. She is also the author of “Get to Aha!” a seminal primer about corporate positioning. Andy is a much sought after marketing expert in Silicon Valley, having been on the forefront of marketing, branding, positioning and communicating “The Next Big Thing” for over 30 years. She is well known for helping Steve Jobs launch the Macintosh and later working with him at NeXT and Pixar."
Susan Galbraith, MD, Ph.D
As the Executive Vice President for Oncology R&D at AstraZeneca, Susan has global accountability for the Oncology portfolio from discovery through to late-stage development. Since joining AstraZeneca in 2010, Susan has been instrumental in bringing seven new medicines to patients, four of which are now blockbusters. Prior to AstraZeneca, Susan held senior Oncology R&D roles at Bristol-Myers Squibb. A Clinical Oncologist by background, Susan trained in medicine at Manchester and Cambridge Universities and has a PhD from the University of London. She holds an honorary Doctorate of Medical Science from the Institute of Cancer Research and is a Fellow of the Academy of Medical Sciences. Susan serves on the American Association for Cancer Research Board of Directors, the Institute of Cancer Research Scientific Advisory Board and the European Association of Cancer Research Advisory Council; she is also the current Chair of the Board at Definiens AG.
Juncal Arbelaiz, Ph.D
Juncal Arbelaiz received her Ph.D. in Applied Mathematics from the Massachusetts Institute of Technology in 2022, and she is currently a Schmidt Science Postdoctoral Fellow at the Center for Statistics and Machine Learning at Princeton University. Her research is on the design of distributed and decentralized systems. She has received several awards and fellowships during her career, such as being named a Rising Star in EECS in 2021, being honored with an Anita Borg scholarship from Google, and awarded the National Award for Academic Excellence of the Spanish Government.
